Seaweed-derived composition for losing weight and preparation method thereof
Through the combination of seaweed saccharin extract and specific compounds, a weight loss composition with no side effects and good flavor was prepared, which solved the problem that existing weight loss products could not effectively reduce body fat, and achieved the situation of not resisting hunger Effectively lose weight and improve skin condition.
Patent Information
- Application Number
- CN202410876683.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-02
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing weight loss products cannot effectively reduce body fat, and have side effects, inconvenient use and poor taste, making it difficult to effectively lose weight when the human body is static.
Using the extract of the saccharin algae in seaweed combined with 1,3 butanediol, water, 1,2-hexanediol and parahydroxyacetophenone, a composition is prepared by specific preparation steps to promote fat burning, Inhibit fat storage and stimulate leptin release to form a weight loss composition with no side effects and good flavor.
This composition can promote fat burning, inhibit the formation of mature adipocytes, reduce fat storage, stimulate leptin release, improve skin roughness, restore skin smoothness and firmness, and achieve effective weight loss without resisting hunger.
Smart Images

Figure CN118985897A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of health care products, in particular to a composition derived from seaweed for weight loss and a preparation method thereof. Background Art
[0002] Obesity refers to a certain degree of obvious overweight and excessive fat layer. It is a state caused by excessive accumulation of body fat, especially triglycerides. Modern people are under increasing work pressure and spend too much time at work and study, which leads to less exercise time. Sitting for a long time and not moving leads to obesity, constipation, and increased weight and body fat. In addition, modern people are busy at work and always eat fast food and takeout. Their unreasonable diet structure, excessive nutrition intake, unbalanced nutrition, high oil content, high salt content, etc., lead to increased body fat. Obesity is mainly attributed to excessive food intake and too little exercise. Obesity not only brings about changes in body shape, but also causes an increase in the incidence of chronic diseases such as hypertension, hyperlipidemia, diabetes, coronary heart disease, and malignant tumors.
[0003] The weight loss products on the market are generally divided into the following categories: 1. Excretion-promoting weight loss products, which promote intestinal peristalsis and can cause excretion in a short time after taking. This method has obvious physical sensations and is very fast, but it will be accompanied by abdominal discomfort and bloating. Long-term use will also cause damage to the intestines, and the weight loss effect is not obvious; 2. Meal replacement products, which reduce energy intake through meal replacements, have bad taste, are easy to get hungry, are not easy to stick to, and can cause rebound; 3. Weight loss drugs, which have great side effects and are harmful to the body; 4. Exercise and fitness, healthy weight loss is good for the body, but due to limited time, most people cannot stick to it for personal reasons and are unwilling to exercise.
[0004] Therefore, the weight loss products currently available on the market cannot effectively reduce body fat when the human body is in a static state, and the weight loss effect is poor.
[0005] Excessive accumulation of body fat due to excessive food intake or changes in body metabolism causes excessive weight gain and causes pathological and physiological changes or lurking in the human body. At the same time, with the improvement of people's living standards, obesity has become more and more common and occurs in all age groups.
[0006] For example, Chinese utility model patent CN117618297A proposes a preparation method and application of a Coral Glehnia extract, which solves the problem of low extraction rate of existing Coral Glehnia by utilizing non-high temperature crushing and organic-water composite dissolution to achieve complete immersion and dissolution of the Coral Glehnia material after pulverization, thereby increasing the solid-liquid contact area and achieving the effect of improving the extraction rate.
[0007] Currently, there are many drugs and methods for treating obesity, but there are few products that have obvious therapeutic effects, no side effects, good flavor, and are easy to use. Therefore, it is necessary to develop a new weight loss composition to solve this defect. Summary of the invention
[0008] 1. Technical issues to be solved
[0009] In view of the shortcomings of the prior art, the present invention provides a composition derived from seaweed for weight loss and a preparation method thereof, which has the advantages of obvious therapeutic effects, no side effects, good flavor and easy use, and solves the problem in the prior art of how to effectively lose weight without the need to resist hunger.
[0010] (II) Technical solution
[0011] To achieve the above object, the present invention provides the following technical solution: a method for preparing a composition derived from seaweed for weight loss, comprising the following steps:
[0012] Step 1: The cleaned kelp is washed, minced and ground into a homogenate in a dilute acid solution to prepare a kelp slurry;
[0013] Step 2: cooking the prepared Alpinia sphaerocephala slurry at an absolute pressure of 1-5 MPa and a temperature of 117-125° C. for 0.5-2 h to obtain Alpinia sphaerocephala decomposition liquid;
[0014] Step 3: adding alkali solution to the prepared decomposition solution of Algae to adjust the pH value to 12.0-14.0, and decomposing it at a temperature of 40-50° C. and a pressure of 1.5 MPa for 1-2 hours;
[0015] Step 4: adding a surfactant and an ethanol solution to the degraded decomposition liquid of the chrysanthemum sphaerocephalum, reacting at 40-50° C. for 3-5 hours to obtain a mixed liquid;
[0016] Step 5: The pH value of the mixed solution is adjusted to 4-6.5, the temperature is adjusted to 30-40°C, lysozyme is added and stirred thoroughly, and then one or more of polygalacturonase, pectate lyase and pectinesterase are added and mixed and stirred evenly, and fermented and filtered to obtain the extract of the kelp.
[0017] Preferably, the average relative molecular weight of the Chrysopsis pilosula extract is 500-50000Da.
[0018] A composition derived from seaweed for weight loss, the raw materials comprising by weight:
[0019] Take 5 parts of the extract of Cordyceps sinensis, 49 parts of 1,3-butylene glycol, 43.5 parts of water, 2 parts of 1,2-hexanediol and 0.5 parts of p-hydroxyacetophenone.
[0020] Preferably, the composition further comprises the following preparation steps:
[0021] Step 1: Take 5 parts of the obtained Alpinia serrata extract and 49 parts of 1,3-butylene glycol, mix and stir evenly to prepare solution a;
[0022] Step 2: Take 5 parts of the obtained Alpinia serrata extract and 30 parts of water, mix and stir evenly to prepare solution B;
[0023] Step 3: Take 5 parts of the obtained Alpinia serrata extract and 2 parts of 1,2-hexanediol, mix and stir evenly to prepare solution C;
[0024] Step 4: Take 5 parts of the obtained Cordyceps sinensis extract and 0.5 parts of p-hydroxyacetophenone, mix and stir evenly to prepare solution d.
[0025] Preferably, the method further comprises the following preparation steps:
[0026] Add solutions a, b, c and d into the same reaction kettle, heat to 80-85°C, mix and stir evenly, keep warm for 3 hours, cool to 38°C, filter out the material, and obtain a seaweed-derived composition.
[0027] Preferably, the seaweed-derived composition is used for body shaping massage.
[0028] (III) Beneficial effects
[0029] Compared with the prior art, the present invention provides a composition derived from seaweed for weight loss and a preparation method thereof, which has the following beneficial effects:
[0030] The composition derived from seaweed for weight loss and the preparation method thereof have the effects of promoting fat burning, inhibiting the formation of mature fat cells, reducing fat storage, stimulating the release of leptin, restoring the skin, reducing skin roughness, repairing the skin, and making the skin smoother and firmer. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 It is a comparison chart of the inhibition rate of fatty acid synthase in the present invention;
[0032] Figure 2 It is a comparison chart of the antibacterial rate of fatty acid synthase in the present invention;
[0033] Figure 3 is a comparison chart of the inhibition rate of fatty acid synthase in the present invention;
[0034] Figure 4 A comparison chart of the survival rate of 3T3L1 adipocytes in the present invention;
[0035] Figure 5 It is a comparison diagram of the lipid accumulation inhibition rate in the present invention;
[0036] Figure 6It is a comparison chart of the glycerol release amount uM in the present invention. DETAILED DESCRIPTION
[0037] The technical solutions in the embodiments of the present application are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.
[0038] In addition, in this application, descriptions such as "first", "second", etc. are only used for descriptive purposes and cannot be understood as indicating or implying their relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In addition, the technical solutions between the various embodiments can be combined with each other, but they must be based on the ability of ordinary technicians in this field to implement them. When the combination of technical solutions is contradictory or cannot be implemented, it should be deemed that such combination of technical solutions does not exist and is not within the scope of protection required by this application.
[0039] The present application is described below with reference to the accompanying drawings and specific embodiments:
[0040] The present application embodiment provides a method for preparing a composition derived from seaweed for weight loss, comprising the following steps:
[0041] Step 1: The cleaned kelp is washed, minced and ground into a homogenate in a dilute acid solution to prepare a kelp slurry;
[0042] Step 2: cooking the prepared Alpinia sphaerocephala slurry at an absolute pressure of 1-5 MPa and a temperature of 117-125° C. for 0.5-2 h to obtain Alpinia sphaerocephala decomposition liquid;
[0043] Step 3: adding alkali solution to the prepared decomposition solution of Algae to adjust the pH value to 12.0-14.0, and decomposing it at a temperature of 40-50° C. and a pressure of 1.5 MPa for 1-2 hours;
[0044] Step 4: adding a surfactant and an ethanol solution to the degraded decomposition liquid of the chrysanthemum sphaerocephalum, reacting at 40-50° C. for 3-5 hours to obtain a mixed liquid;
[0045] Step 5: The pH value of the mixed solution is adjusted to 4-6.5, the temperature is adjusted to 30-40°C, lysozyme is added and stirred thoroughly, and then one or more of polygalacturonase, pectate lyase and pectinesterase are added and mixed and stirred evenly, and fermented and filtered to obtain the extract of the kelp.
[0046] In some embodiments, the average relative molecular weight of the Chrysopsis pilosula extract is 500-50000 Da.
[0047] A composition derived from seaweed for weight loss, the raw materials comprising by weight:
[0048] Take 5 parts of the extract of Cordyceps sinensis, 49 parts of 1,3-butylene glycol, 43.5 parts of water, 2 parts of 1,2-hexanediol and 0.5 parts of p-hydroxyacetophenone.
[0049] In some embodiments, the composition further comprises the following preparation steps:
[0050] Step 1: Take 5 parts of the obtained Alpinia serrata extract and 49 parts of 1,3-butylene glycol, mix and stir evenly to prepare solution a;
[0051] Step 2: Take 5 parts of the obtained Alpinia serrata extract and 30 parts of water, mix and stir evenly to prepare solution B;
[0052] Step 3: Take 5 parts of the obtained Alpinia serrata extract and 2 parts of 1,2-hexanediol, mix and stir evenly to prepare solution C;
[0053] Step 4: Take 5 parts of the obtained Cordyceps sinensis extract and 0.5 parts of p-hydroxyacetophenone, mix and stir evenly to prepare solution d.
[0054] In some embodiments, the following preparation steps are also included:
[0055] Add solutions a, b, c and d into the same reaction kettle, heat to 80-85°C, mix and stir evenly, keep warm for 3 hours, cool to 38°C, filter out the material, and obtain a seaweed-derived composition.
[0056] In some embodiments, the case of the application in the shaping massage cream is as follows: Table 1
[0057]
[0058]
[0059] Production process: add serial numbers 1.3.4.11.14.15 into the emulsifying pot, heat to 88 degrees and stir to disperse evenly; add 2.5.6.7.8.9.10.13 into the oil phase pot, heat to 88 degrees and disperse evenly; pump the oil phase pot into the emulsifying pot and homogenize to disperse evenly; cool to 45 degrees, add 12.16 and stir evenly; that's it.
[0060] The above is only a preferred embodiment of the present invention, a composition derived from seaweed for weight loss is applied to the field of cosmetics, "shaping massage cream", and the shaping massage cream is measured.
[0061] The results are as follows:
[0062] Test scheme 1: Expression of AQP8 in mature adipocytes treated with shaping massage cream (cultured for 3 weeks) The synthesis of AQP8 was visualized by immunolabeling, and the synthesis of AQP8 in treated mature adipocytes increased by 50%;
[0063] Test scheme 2: normal human dermal fibroblasts (37 years old / female) were treated with the shaping massage cream for 24 hours, and the synthesis of AQP8 was visualized by immunolabeling. The results showed that the synthesis of AQP8 in the treated fibroblasts was +58%;
[0064] Test scheme 3: Human bone marrow mesenchymal stem cells differentiated into mature adipocytes and treated with a shaping massage cream for 5 hours, and the non-esterified fatty acids (free fatty acids (NEFA)) released by adipocytes were quantitatively analyzed. Fatty acid release +74%, which directly maintains the dynamic balance of mitochondria, and the synthesis of AQP8 was increased;
[0065] Test scheme 4: Use the shaping massage cream to inhibit the expression of the synthesis rate of fatty acid synthase (FAS), resulting in a 27% reduction in fatty acid synthase;
[0066] Test plan 5: Using a shaping massage cream to increase the expression of adiponectin, the synthesis rate of adiponectin increased by 30%.
[0067] Test plan 6: 80 obese volunteers were selected. After applying the shaping massage cream to the same part of the body for 15 days, more than 2 / 3 of the volunteers found that their skin was smoother and firmer, achieving a comprehensive reshaping effect that eliminates fat, restores skin firmness and effectively improves roughness.
[0068] See also Figure 1-6 , Test Example 1, Inhibitory effect of the composition on fatty acid synthase
[0069] 1. Test materials: the compositions with fat-reducing and weight-loss effects prepared in Examples 1 to 4, and the compositions prepared in Comparative Examples 1 to 6.
[0070] Composition with fat-reducing and weight-loss effects
[0071] 2. Test methods:
[0072] (1) Fresh duck liver → rinse → chop → homogenize → centrifuge at low temperature and low speed → centrifuge at low temperature and high speed → extract Take fresh duck liver, cut off the fat and white tendons and fat on the liver with scissors; rinse with frozen physiological saline three times to remove blood and dirt on the surface; chop with scissors and add frozen phosphate buffer at a weight ratio of 1:1.8, homogenize in a tissue homogenizer (stop for 20 seconds after homogenization for 10 seconds, otherwise it is easy to heat up); put into a centrifuge tube and centrifuge at 8000r / min at 4℃ for 15min to remove fat particles and cell nuclei; take the supernatant and centrifuge at 12000r / min at 4℃ for 30min. Take the supernatant and store it below -40℃ for later use.
[0073] (2) Take 100 μL of the test substance of different concentrations and dissolve it in 200 μL of 1 mmoL / EDTA, 0.9 mL of 0.1 mol / L potassium phosphate buffer at pH 7, and the substrate concentrations are 400 μL of acetyl CoA 6 μmoL / L, 200 μL of malonyl CoA 12 μmoL / L, and 150 μL of NADPH 37.5 μmoL / L. Keep it in a constant temperature water bath at 37°C for 5 min, and add 50 μL of the diluted high-speed centrifugation supernatant to start the enzyme reaction. Through the study of the activity characteristics of fatty acid synthase, it is determined that the inhibitory effect of the test substance on fatty acid synthase can be calculated by comparing the absorbance value at 340 nm with that of the control group after terminating the reaction for 60 s. The control group is 1 mL of 0.1 mol / L potassium phosphate buffer. According to the enzyme activity calculation formula, the inhibition rate formula under the same dilution multiple conditions can be simplified as: Inhibition rate (%) = [(A1-A2) / A1]*100%, where A1 and A2 are the absorbance values of the blank control and sample solutions, respectively.
[0074] 3. Test results:
[0075] like Figure 1 As shown, the concentration of the compositions with fat-reducing and weight-loss effects prepared in Comparative Examples 1 to 6 used was 80 mg / mL. The compositions prepared in Comparative Examples 1 to 6 were subjected to experiments on the inhibition of fatty acid synthase. The results showed that the compositions prepared in Comparative Examples 1 to 6 had a poorer inhibitory effect on fatty acid synthase than the compositions prepared in Examples 1 to 4.
[0076] like Figure 2 As shown, the concentration of the compositions with fat-reducing and weight-loss effects prepared in Examples 1 to 4 used was 80 mg / mL. The compositions of different Examples were subjected to experiments on the inhibition of fatty acid synthase. The results showed that the composition prepared in Example 2 had the best inhibitory effect on fatty acid synthase.
[0077] like Figure 3As shown, the concentrations of the composition with fat-reducing and weight-loss effects prepared in Example 2 used were 0, 20, 40, 60, 80, and 100 mg / mL, respectively. The compositions prepared in Example 2 with different concentration gradients were tested for their inhibitory effects on fatty acid synthase. The results showed that as the concentration of the composition prepared in Example 2 increased, its inhibitory effect on fatty acid synthase became better.
[0078] Test Example 2: 3T3-L1 adipocyte toxicity test
[0079] Test material: the composition with fat-reducing and weight-loss effect prepared in Example 2
[0080] Test method:
[0081] 3T3-L1 adipocytes in the logarithmic growth phase were digested with pancreatin (0.25%, containing EDTA), centrifuged, and inoculated in a 96-well plate at a density of 1*105 / mL, with 100 μL of cell suspension per well. After 24 hours of plating, the old culture medium was discarded, washed twice with PBS, and the composition of Example 2 containing different concentration gradients was added to the 96-well plate, and the 96-well plate with the sample was placed in a CO2 incubator. After 48 hours, the absorbance was measured at 450nm using the CCK-8 method under an ELISA reader with 630nm as the reference wavelength, and the measurement results were recorded. The cell survival rate was calculated by formula (1).
[0082] Cell survival rate = (test well OD450 - blank OD450) / (control well OD450 - blank OD450) × 100%
[0084] 3. Test results:
[0085] The concentrations of the composition with fat-reducing and weight-loss effects prepared in Example 2 used in Experimental Example 2 were 0, 12.5,
[0086] 25, 50, 100uM, the composition prepared in Example 2 with different concentration gradients was applied to 3T3-L1 adipocytes, and the cell survival rate was calculated. Figure 4 It can be seen that after 48 hours of adding the sample, the cell survival rate corresponding to the concentration of 0-100uM is about 88-99%, and it is concentration-dependent. From the 3T3-L1 adipocyte toxicity test in Experimental Example 2, it can be concluded that the composition prepared in Example 2 is almost non-toxic to 3T3-L1 adipocytes when the concentration gradient is set at 12.5 and 25uM, and can be used for the experiment of triglyceride and glycerol in 3T3-L1 adipocytes B16F10 cells.
[0087] Test Example 3: Method for quantitative detection of triglycerides
[0088] 1. Test materials: the composition with fat-reducing and weight-loss effects prepared in Example 2
[0089] 2. Test methods:
[0090] In order to quantitatively detect the effect of the composition on fat accumulation, the intracellular triglyceride content was determined using a triglyceride kit. The cells were incubated with the composition in a cell culture incubator at 37°C, 5% CO2 for 24 hours. The supernatant was discarded and the cells were digested with 0.25% trypsin-EDTA. The accumulated triglyceride level in the cells was measured according to the instructions of the triglyceride assay kit (A110-1) to determine the degree of fat accumulation.
[0091] 3. Test results:
[0092] In Experimental Example 3, the composition with fat-reducing and weight-loss effects prepared in Example 2 was used at concentrations of 0, 12.5, and 25 uM, respectively. The composition prepared in Example 2 with different concentration gradients was applied to 3T3-L1 adipocytes. Figure 5 It can be seen that the composition prepared in Example 2 inhibits lipid accumulation in a dose-dependent manner. When the concentration of the composition prepared in Example 2 is equal to 25 μM, the composition prepared in Example 2 significantly inhibits lipid accumulation compared with the control group. When the concentration of the composition prepared in Example 2 is 25 μM, lipid accumulation is reduced by 28.8%, which is significantly reduced by 28.8% compared with the control group.
[0093] Test Example 4: Method for quantitative detection of glycerol
[0094] 1. Test materials: the composition with fat-reducing and weight-loss effects prepared in Example 2
[0095] 2. Test methods:
[0096] In order to quantitatively detect the effect of the composition on cellular lipolysis, a glycerol kit was used for determination. The cells and the composition at different concentrations were incubated in a cell culture incubator at 37°C and 5% CO2 for 24 hours. The culture medium used DMEM without serum and phenol red, because the serum and phenol red in the culture medium would affect the determination of the results. The supernatant was collected and centrifuged at 12000×g for 5 minutes. According to the instructions of the glycerol enzyme assay kit (E1002), the glycerol content in the supernatant was measured to determine the degree of lipolysis.
[0097] 3. Test results:
[0098] like Figure 6As shown, the concentrations of the composition with fat-reducing and weight-loss effects prepared in Example 2 used in Experiment 4 were 0, 12.5, and 25 uM, respectively. The compositions prepared in Example 2 with different concentration gradients were applied to 3T3-L1 adipocytes. When the concentration of the composition prepared in Example 2 was low, the glycerol content test showed no significant difference from that of the control group. As the concentration of the composition prepared in Example 2 increased, the effect of lipid decomposition became better. Compared with the control group, the composition prepared in Example 2 was able to significantly increase the amount of glycerol released, and this result was consistent with the result of inhibiting lipid accumulation ( Figure 5 ), indicating that the composition prepared in Example 2 exhibits a significant ability to promote lipolysis.
[0099] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present application. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine different embodiments or examples described in this specification.
[0100] In addition, the technical solutions between the various embodiments can be combined with each other, but they must be based on the fact that they can be implemented by ordinary technicians in this field. When the combination of technical solutions is contradictory or cannot be implemented, it should be deemed that such combination of technical solutions does not exist and is not within the scope of protection required by this application.
[0101] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for preparing a composition derived from seaweed for weight loss, characterized in that: The steps include: Step 1: The cleaned kelp is washed, minced and ground into a homogenate in a dilute acid solution to prepare a kelp slurry; Step 2: cooking the prepared Alpinia sphaerocephala slurry at an absolute pressure of 1-5 MPa and a temperature of 117-125° C. for 0.5-2 h to obtain Alpinia sphaerocephala decomposition liquid; Step 3: adding alkali solution to the prepared decomposition solution of Algae to adjust the pH value to 12.0-14.0, and decomposing it at a temperature of 40-50° C. and a pressure of 1.5 MPa for 1-2 hours; Step 4: adding a surfactant and an ethanol solution to the degraded decomposition liquid of the chrysanthemum sphaerocephalum, reacting at 40-50° C. for 3-5 hours to obtain a mixed liquid; Step 5: The pH value of the mixed solution is adjusted to 4-6.5, the temperature is adjusted to 30-40°C, lysozyme is added and stirred thoroughly, and then one or more of polygalacturonase, pectate lyase and pectinesterase are added and mixed and stirred evenly, and fermented and filtered to obtain the extract of the kelp.
2. The method for preparing a composition derived from seaweed for weight loss according to claim 1, characterized in that: The average relative molecular weight of the extract of the diatomaceous algae is 500-50000Da.
3. A composition derived from seaweed for weight loss, according to the method for preparing a composition derived from seaweed for weight loss according to any one of claims 1-2, characterized in that: The raw materials include by weight: Take 5 parts of the extract of Cordyceps sinensis, 49 parts of 1,3-butylene glycol, 43.5 parts of water, 2 parts of 1,2-hexanediol and 0.5 parts of p-hydroxyacetophenone.
4. The composition derived from seaweed for weight loss according to claim 3, characterized in that: The composition also includes the following preparation steps: Step 1: Take 5 parts of the obtained Alpinia serrata extract and 49 parts of 1,3-butylene glycol, mix and stir evenly to prepare solution a; Step 2: Take 5 parts of the obtained Alpinia serrata extract and 30 parts of water, mix and stir evenly to prepare solution B; Step 3: Take 5 parts of the obtained Alpinia serrata extract and 2 parts of 1,2-hexanediol, mix and stir evenly to prepare solution C; Step 4: Take 5 parts of the obtained Cordyceps sinensis extract and 0.5 parts of p-hydroxyacetophenone, mix and stir evenly to prepare solution d.
5. The composition derived from seaweed for weight loss according to claim 4, characterized in that: The following preparation steps are also included: Add solutions a, b, c and d into the same reaction kettle, heat to 80-85°C, mix and stir evenly, keep warm for 3 hours, cool to 38°C, filter out the material, and obtain a seaweed-derived composition.
6. A composition derived from seaweed for weight loss according to any one of claims 3 to 5, characterized in that: The seaweed-derived composition is used for body shaping massage.
